Skip to main content
PepStack
Blutwerte · Marker

SHBG

Sex Hormone Binding Globulin · Sexualhormon-bindendes Globulin

Hormone — Reproduktionsachse
Einheit:
nmol/L

SHBG quantifies the concentration of sex hormone-binding globulin in the blood, which regulates the bioavailability of sex steroids.

Reference Ranges

Reference
18–144nmol/L
18
20
40
144
LowNormalHigh
Reference
Optimal
Unit · nmol/L

Ranges can vary based on age, sex, and laboratory standards.

Overview

Übersicht

Sex Hormone-Binding Globulin (SHBG) is a glycoprotein synthesized primarily in the liver, which binds sex steroids such as testosterone and estradiol with high affinity. It plays a crucial role in regulating the bioavailability of these hormones by controlling their distribution between protein-bound and free states in the bloodstream. Researchers have found that SHBG levels are influenced by various factors, including hormonal balance, liver function, and metabolic conditions. Clinically, SHBG is significant in evaluating disorders related to androgen metabolism, such as polycystic ovary syndrome (PCOS) and gynecomastia. Elevated SHBG levels are associated with conditions like hyperthyroidism and hypogonadism, while low levels are linked to insulin resistance and non-alcoholic fatty liver disease. For athletes and biohackers, SHBG levels can impact performance and recovery by affecting the availability of testosterone, a key hormone in muscle growth and energy metabolism. However, SHBG levels can be confounded by factors such as age, sex, and the use of certain medications. Time-of-day variations and fasting status can also influence SHBG measurements, necessitating standardized testing conditions for accurate assessment.

Klinische Bedeutung

Elevated SHBG levels may indicate hyperthyroidism, hypogonadism, or liver dysfunction, while reduced levels can suggest insulin resistance, obesity, or polycystic ovary syndrome.

Dynamics

Trend Interpretation

Rising Values

Progressively rising SHBG values may suggest worsening liver function or increased estrogen activity. Re-test in 4-6 weeks if outside the normal range.

Falling Values

Falling SHBG levels may indicate increasing insulin resistance or androgen activity.

Re-test Interval

4 weeks if outside optimal range

Etiology

Causes — High & Low

Cause

Elevated Levels

  • Hyperthyroidism
  • Hypogonadism
  • Androgen insensitivity
  • Hepatic cirrhosis
  • Use of estrogens
Cause

Low Levels

  • Insulin resistance
  • Obesity
  • Polycystic ovary syndrome
  • Hypothyroidism
  • Excessive androgen activity
Protocol

How to Optimize

Lever

Lifestyle

  • Regular physical activity
  • Weight management
  • Stress reduction
Lever

Nutrition

  • Balanced diet with adequate protein
  • Reduced intake of refined sugars
Lever

Supplementation

  • Omega-3 fatty acids
  • Vitamin D

Note:

Consult a healthcare provider before making significant lifestyle or dietary changes, especially if underlying health conditions are present.

Testing Guidelines

✓Fasting Not Required
✓Not Time-Sensitive

SHBG levels can vary with circadian rhythms; morning samples are preferred for consistency.

Testing Frequency

Annually for adults with risk factors, or as advised by a healthcare provider.

Interfering Factors

  • Use of oral contraceptives
  • Thyroid medications
  • Liver disease

Related Peptides & Hormones

Testosterone

Correlated with

hormone

Open Research Questions

Current research suggests that the reference ranges for SHBG levels in various populations, particularly in men with gynecomastia and women with polycystic ovary syndrome, remain debated. Researchers have not yet established optimal SHBG targets for therapeutic interventions or fully elucidated the confounding effects of insulin resistance and thyroid function on SHBG levels. Additionally, clinical questions regarding the role of SHBG in the pathogenesis of conditions like NAFLD and its potential as a therapeutic target remain unanswered.

40 Research Publications

2,080

Total Citations

16

Human/RCT

4.3

Avg. Influence

2025

Latest

Sort
Filter
#01

Estrogen: a master regulator of bioenergetic systems in the brain and body.

ReviewInfluence15.0
506
This study highlighted estrogen's role as a regulator of metabolic systems in the body. Researchers found that estrogen influences energy metabolism and may impact cognitive decline during menopause. The study suggests that biomarker profiles could help identify women at risk for metabolic and cognitive issues.
View on PubMed
#02

The endocrine system and ageing.

ReviewInfluence10.0
303
This article discussed changes in the endocrine system due to aging, including increased SHBG levels. Researchers observed that these hormonal changes can lead to various health issues, emphasizing the complexity of aging's impact on hormone regulation.
View on PubMed
#03

Sex hormone binding globulin: origin, function and clinical significance.

ReviewInfluence7.0
273
This review detailed the origin and function of sex hormone-binding globulin (SHBG). Researchers found that SHBG levels are influenced by various factors, including hormonal balance and diseases, and its measurement can aid in evaluating androgen metabolism disorders.
View on PubMed
#04

Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome.

Qu Xianqin & Donnelly Richard · International journal of molecular sciences · 2020

ReviewInfluence2.0
188
This review focused on sex hormone-binding globulin (SHBG) as a potential biomarker in polycystic ovary syndrome (PCOS). Researchers observed that low SHBG levels correlate with insulin resistance and ovarian pathology, suggesting its role in the pathogenesis of PCOS.

Key findings

  1. 01Researchers observed a negative correlation between SHBG levels and markers of liver disease and insulin resistance.
  2. 02Low SHBG levels may lead to higher androgen levels, contributing to the symptoms of PCOS.
  3. 03Emerging evidence indicates that SHBG could be a useful biomarker for diagnosing and managing PCOS.
View on PubMed
#05

Sex hormone-binding globulin and polycystic ovary syndrome.

ReviewInfluence4.0
143
This review explored the relationship between sex hormone-binding globulin (SHBG) and polycystic ovary syndrome (PCOS). Researchers found that low SHBG levels are associated with hyperandrogenism and insulin resistance in women with PCOS. The study highlights the importance of SHBG in understanding PCOS pathology.
View on PubMed
#06

EAA clinical practice guidelines-gynecomastia evaluation and management.

ReviewInfluence8.0
139
This study examined clinical practice guidelines for evaluating and managing gynecomastia in men. Researchers found that sex hormone-binding globulin (SHBG) levels, along with other hormonal assessments, are important in the evaluation of gynecomastia to identify underlying conditions. The study emphasizes the need for thorough medical history and physical examinations.
View on PubMed
#07

Comparative effects of daily and weekly boron supplementation on plasma steroid hormones and proinflammatory cytokines.

HumanInfluence2.0
121
This study investigated the effects of boron supplementation on plasma steroid hormones and inflammatory biomarkers. Researchers observed that boron supplementation significantly decreased SHBG levels and proinflammatory cytokines while increasing free testosterone levels. The findings suggest a potential role for boron in modulating hormone levels.
View on PubMed
#08

Endocrinology of gynaecomastia.

ReviewInfluence4.0
81
This review explored the endocrinology of gynecomastia, noting its occurrence across various age groups. Researchers observed that SHBG levels, among other hormonal tests, are crucial for identifying underlying causes of gynecomastia, particularly in older men where malignancy must be ruled out.
View on PubMed
#09

Sex hormone-binding globulin: biomarker and hepatokine?

Simons Pomme I H G, et al. · Trends in endocrinology and metabolism: TEM · 2021

Review
63
This review highlighted recent findings on sex hormone-binding globulin (SHBG) as a hepatokine. Researchers observed that SHBG levels are linked to metabolic syndrome and type 2 diabetes, suggesting potential therapeutic targets for these conditions.

Key findings

  1. 01Researchers observed that genetic factors influencing SHBG levels are associated with metabolic syndrome.
  2. 02They identified a direct link between low SHBG levels and the development of type 2 diabetes in women.
  3. 03The study suggests that therapies aimed at raising SHBG could help address disorders like type 2 diabetes and polycystic ovary syndrome.
View on PubMed
#10

Sex hormone binding globulin as a potential drug candidate for liver-related metabolic disorders treatment.

Bourebaba Nabila, et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022

ReviewInfluence1.0
59
This review discussed the potential of SHBG as a therapeutic target for liver-related metabolic disorders. Researchers found that SHBG levels are linked to insulin resistance and metabolic syndrome, indicating its role in managing conditions like obesity and diabetes.

Key findings

  1. 01Researchers observed that SHBG levels are linked to insulin resistance and may predict the risk of type 2 diabetes.
  2. 02Increased inflammation in the body is associated with lower levels of SHBG.
  3. 03The review suggests that SHBG could be a promising candidate for developing new therapies for metabolic disorders such as non-alcoholic fatty liver disease.
View on PubMed

Clinical Trials (1)

1

Total Trials

250

Total Enrolled

Sex Hormone Binding Globulin, Testosterone and Glycemic Control in Patients With Type 2 Diabetes

NCT03519529COMPLETED
Sponsor

Nanjing First Hospital, Nanjing Medical University

Enrollment

250

Started

2015

Primary outcome

sex hormone-binding globulin

Type2 Diabetes

Publication Trend

Research publications about SHBG over time

10total
1
'13
1
'16
1
'18
1
'19
1
'20
3
'21
2
'22

Track your bloodwork in PepStack

Log lab results, track trends and optimize your biomarkers over time.

Legal Disclaimer

This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer